Last updated on November 2019

Parkinson’s disease patients and their caregivers are needed for a Washington University School of Medicine research study.

---

Brief description of study

Parkinson’s disease patients and their caregivers are needed for a Washington University School of Medicine research study.

Detailed Study Description

Dr. Kevin Black will look at the safety and effectiveness of an investigational drug compared to placebo (inactive substance) in the treatment of Parkinson’s disease with psychosis. Participation in this study may last up to 12 weeks. There will be a screening visit lasting about 3 hours and up to 5 additional study visits. There may be no direct benefit to the participants. Risks will be discussed as part of the informed consent process. Compensation is available.

Patient Inclusion Criteria:

• 40 or older
• Parkinson’s disease
• Symptoms of psychosis including visual and/or auditory hallucinations, and/or delusions

Patient Exclusion Criteria:

• Psychosis prior to the onset of Parkinson’s